Loading clinical trials...
Loading clinical trials...
A Multicenter, Randomized, Double-Blind Study Comparing the Efficacy and Safety of Ixekizumab Versus Placebo in Patients With Moderate-to-Severe Genital Psoriasis
Conditions
Interventions
Ixekizumab
Placebo
Locations
34
United States
Southern California Dermatology
Santa Ana, California, United States
Clinical Science Institute
Santa Monica, California, United States
Olympian Clinical Research
Tampa, Florida, United States
Advanced Medical Research
Sandy Springs, Georgia, United States
Dawes Fretzin Clinical Research
Indianapolis, Indiana, United States
The South Bend Clinic
South Bend, Indiana, United States
Start Date
April 1, 2016
Primary Completion Date
February 22, 2017
Completion Date
February 21, 2018
Last Updated
September 16, 2019
NCT07474792
NCT06857942
NCT06979453
NCT07471048
NCT07449234
NCT07116967
Lead Sponsor
Eli Lilly and Company
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions